GlassScriptPhysician profile
Manuel Ybarra
NPI 1053572503
$39,402.60
in general payments reported to CMS, 2019-2025
51 companies · $4,766 in 2025
The $4,766 reported for 2025 was more than what 93% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,839 · 2020: $3,493 · 2021: $4,879 · 2022: $4,588 · 2023: $7,938 · 2024: $6,899 · 2025: $4,766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Education: $790 · Travel and Lodging: $341 · Entertainment: $47.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,424.95 |
| Education | $789.80 |
| Travel and Lodging | $341.11 |
| Entertainment | $47.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $13,909.25 | 2019-2024 | Senza |
| Abbott Laboratories | $8,758.15 | 2019-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $2,825.17 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Painteq LLC | $1,759.76 | 2023-2024 | Painteq |
| Globus Medical, INC. | $1,434.18 | 2025 | Senza, Vyrsa V1 |
| Teva Pharmaceuticals USA, INC. | $1,162.06 | 2019-2022 | |
| Mml US, INC. | $1,131.94 | 2023-2025 | Reactiv8 |
| Vertiflex, INC. | $1,051.80 | 2019 | |
| Nalu Medical, INC. | $910.18 | 2021-2024 | Nalu Neurostimulation System |
| Abbvie INC. | $719.73 | 2021-2025 | Ubrelvy |
| Si-Bone, INC. | $681.00 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $672.60 | 2019-2025 | Relistor |
| Spr Therapeutics, INC | $438.38 | 2019-2025 | Sprint Pns System |
| Zyla Life Sciences, INC. | $357.54 | 2019-2020 | |
| Amgen INC. | $334.26 | 2019-2022 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Ybarra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.